BioXcel Therapeutics (BTAI) Finished Goods (2022 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Finished Goods of $92000.0 for Q1 2026, down 48.31% year-over-year from $178000.0 in Q1 2025, and up 148.65% quarter-over-quarter from $37000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Finished Goods (2022 - 2026) Analysis & Trends
BioXcel Therapeutics' Finished Goods history runs 5 years deep, the most recent figure standing at $92000.0 for Q1 2026.
- In Q1 2026, Finished Goods fell 48.31% year-over-year to $92000.0; the TTM figure through Mar 2026 stood at $92000.0 (down 48.31% YoY), while the FY2025 annual figure was $37000.0, down 78.61% from the prior year.
- Finished Goods for Q1 2026 stood at $92000.0, up from $37000.0 in the prior quarter.
- The five-year high for Finished Goods was $1.4 million in Q2 2024, with the low at $37000.0 in Q4 2025.
- The 5-year median for Finished Goods is $500000.0 (2022), against an average of $572437.5.
- The sharpest annual moves came in 2023 and 2025: Finished Goods soared 314.33% in 2023, then tumbled 94.97% in 2025.
- BioXcel Therapeutics' Finished Goods stood at $595000.0 in 2022, then tumbled by 31.93% to $405000.0 in 2023, then sank by 57.28% to $173000.0 in 2024, then plunged by 78.61% to $37000.0 in 2025, then surged by 148.65% to $92000.0 in 2026.
- Business Quant data shows BTAI's Finished Goods at $92000.0 in Q1 2026, $37000.0 in Q4 2025, and $65000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.54 Bn | 43.57 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.59 Bn | 39.94 Bn | 2.15 Bn |
| 3 | Zoetis | 32.41 Bn | 30.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.00 Bn | 19.34 Bn | 683.80 Mn |
| 6 | Viatris | 19.03 Bn | 18.14 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.01 Bn | 11.48 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - |
| 10 | BioXcel Therapeutics | 24.24 Mn | 24.24 Mn | 160,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75,000.00 |
| Mar 31, 2026 | 92,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 73,000.00 |
| Mar 31, 2025 | 178,000.00 |
| Dec 31, 2024 | 173,000.00 |
| Sep 30, 2024 | 692,000.00 |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 405,000.00 |
| Sep 30, 2023 | 731,000.00 |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 595,000.00 |
| Sep 30, 2022 | 604,000.00 |
| Jun 30, 2022 | 300,000.00 |